Savara (SVRA) Stock Forecast, Price & News

Savara (NASDAQ:SVRA) Frequently Asked Questions

When is Savara's next earnings date?

Savara is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our earnings forecast for Savara.

How were Savara's earnings last quarter?

Savara Inc (NASDAQ:SVRA) released its quarterly earnings results on Wednesday, March, 30th. The company reported ($0.07) EPS for the quarter, hitting analysts' consensus estimates of ($0.07).
View Savara's earnings history.

Who are Savara's key executives?

Savara's management team includes the following people:

• Robert N. Neville, Chairman of the Board, Chief Executive Officer (Age 51)
• Taneli Jouhikainen, President, Chief Operating Officer (Age 51)
• David L. Lowrance, Chief Financial Officer (Age 50)
• Nevan C. Elam, Independent Director (Age 49)
• Richard J. Hawkins, Independent Director (Age 68)
• Joseph S. McCracken Ph.D., Independent Director (Age 64)
• Matthew Pauls J.D., Independent Director (Age 46) (LinkedIn Profile)
• Yuri Pikover, Independent Director (Age 56)

Who are some of Savara's key competitors?

Some companies that are related to Savara include Stoke Therapeutics (STOK), Atea Pharmaceuticals (AVIR), Kiniksa Pharmaceuticals (KNSA), Eagle Pharmaceuticals (EGRX), AnaptysBio (ANAB), Vanda Pharmaceuticals (VNDA), Rani Therapeutics (RANI), Vaxxinity (VAXX), GH Research (GHRS), Intercept Pharmaceuticals (ICPT), Pharvaris (PHVS), Tricida (TCDA), Imago BioSciences (IMGO), Bicycle Therapeutics (BCYC) and POINT Biopharma Global (PNT).
View all of SVRA's competitors.

What other stocks do shareholders of Savara own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Savara investors own include BioLineRx (BLRX), Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), CEL-SCI (CVM), Geron (GERN), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO), Verastem (VSTM), Agile Therapeutics (AGRX) and Corbus Pharmaceuticals (CRBP).

What is Savara's stock symbol?

Savara trades on the NASDAQ under the ticker symbol "SVRA."

Who are Savara's major shareholders?

Savara's stock is owned by many different retail and institutional investors. Top institutional shareholders include Farallon Capital Management LLC (7.46%), Vanguard Group Inc. (4.23%), State Street Corp (0.24%), Connor Clark & Lunn Investment Management Ltd. (0.12%), JPMorgan Chase & Co. (0.03%) and Concourse Financial Group Securities Inc. (0.00%). Company insiders that own Savara stock include Badrul A Chowdhury, David A Ramsay, David L Lowrance, Joseph S Mccracken and Matthew Pauls.
View institutional ownership trends for Savara.

Which institutional investors are selling Savara stock?

SVRA stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Vanguard Group Inc., and Connor Clark & Lunn Investment Management Ltd..
View insider buying and selling activity for Savara or view top insider-selling stocks.

Which institutional investors are buying Savara stock?

SVRA stock was acquired by a variety of institutional investors in the last quarter, including Farallon Capital Management LLC, and State Street Corp. Company insiders that have bought Savara stock in the last two years include Badrul A Chowdhury, David A Ramsay, David L Lowrance, Joseph S Mccracken, and Matthew Pauls.
View insider buying and selling activity for Savara or or view top insider-buying stocks.

How do I buy shares of Savara?

Shares of SVRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Savara's stock price today?

One share of SVRA stock can currently be purchased for approximately $1.36.

How much money does Savara make?

Savara has a market capitalization of $155.10 million and generates $260 thousand in revenue each year. The company earns $-43.01 million in net income (profit) each year or ($0.26) on an earnings per share basis.

What is Savara's official website?

The official website for Savara is www.savarapharma.com.

How can I contact Savara?

Savara's mailing address is 6836 Bee Cave Road Building III Suite 200, AUSTIN TX, 78746. The company can be reached via phone at 512-614-1848, via email at [email protected], or via fax at 858-552-0876.